ISTH interim guidance on recognition and management of coagulopathy in COVID-19
- PMID: 32338827
- PMCID: PMC9906133
- DOI: 10.1111/jth.14810
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Figures
Comment in
-
RE: ISTH interim guidance to recognition and management of coagulopathy in COVID-19.J Thromb Haemost. 2020 Aug;18(8):2057-2058. doi: 10.1111/jth.14853. Epub 2020 Jul 15. J Thromb Haemost. 2020. PMID: 32302442 Free PMC article. No abstract available.
-
ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A comment.J Thromb Haemost. 2020 Aug;18(8):2060-2063. doi: 10.1111/jth.14860. Epub 2020 Jun 14. J Thromb Haemost. 2020. PMID: 32302462 Free PMC article. No abstract available.
-
Occurrence of pulmonary embolism in a patient with mild clinical expression of COVID-19.Thromb Res. 2020 Aug;192:21-22. doi: 10.1016/j.thromres.2020.05.002. Epub 2020 May 5. Thromb Res. 2020. PMID: 32416365 Free PMC article. No abstract available.
-
Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?Thromb Res. 2021 Dec;208:170-172. doi: 10.1016/j.thromres.2021.11.008. Epub 2021 Nov 16. Thromb Res. 2021. PMID: 34801920 Free PMC article. No abstract available.
References
-
- Williamson D.R., Albert M., Heels‐Ansdell D., et al. Thrombocytopenia in critically ill patients receiving thromboprophylaxis. Chest. 2013;144(4):1207–1215. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
